These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16189091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecalis.
    Lafaurie M, Perichon B, Lefort A, Carbon C, Courvalin P, Fantin B.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2826-30. PubMed ID: 11557476
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis.
    Lefort A, Baptista M, Fantin B, Depardieu F, Arthur M, Carbon C, Courvalin P.
    Antimicrob Agents Chemother; 1999 Mar; 43(3):476-82. PubMed ID: 10049254
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM, García-de-la-Mària C, Brunet M, Armero Y, García-González J, Casals G, Almela M, Quintana E, Falces C, Ninot S, Fuster D, Llopis J, Marco F, Moreno A, Miró JM, Hospital Clinic Endocarditis Study Group.
    J Antimicrob Chemother; 2017 Jun 01; 72(6):1714-1722. PubMed ID: 28204495
    [Abstract] [Full Text] [Related]

  • 8. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
    Arias CA, Singh KV, Panesso D, Murray BE.
    Antimicrob Agents Chemother; 2007 Jun 01; 51(6):2043-7. PubMed ID: 17438057
    [Abstract] [Full Text] [Related]

  • 9. Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.
    Hellinger WC, Rouse MS, Rabadan PM, Henry NK, Steckelberg JM, Wilson WR.
    Antimicrob Agents Chemother; 1992 Jun 01; 36(6):1272-5. PubMed ID: 1416826
    [Abstract] [Full Text] [Related]

  • 10. Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis.
    Lefort A, Saleh-Mghir A, Garry L, Carbon C, Fantin B.
    Antimicrob Agents Chemother; 2000 Nov 01; 44(11):3017-21. PubMed ID: 11036016
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci.
    Francioli P, Moreillon P, Glauser MP.
    J Infect Dis; 1985 Jul 01; 152(1):83-9. PubMed ID: 3925031
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J, Moreillon P, Giddey M, Entenza JM.
    J Antimicrob Chemother; 2006 Dec 01; 58(6):1208-14. PubMed ID: 17030515
    [Abstract] [Full Text] [Related]

  • 14. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N, Piroth L, Lequeu C, Neuwirth C, Portier H, Chavanet P.
    Antimicrob Agents Chemother; 2001 Dec 01; 45(12):3328-33. PubMed ID: 11709304
    [Abstract] [Full Text] [Related]

  • 15. Aminoglycoside-resistant enterococci.
    Basker MJ, Slocombe B, Sutherland R.
    J Clin Pathol; 1977 Apr 01; 30(4):375-80. PubMed ID: 404337
    [Abstract] [Full Text] [Related]

  • 16. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
    Moreillon P, Wilson WR, Leclercq R, Entenza JM.
    Antimicrob Agents Chemother; 2007 May 01; 51(5):1661-5. PubMed ID: 17353251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance.
    Spiegel CA, Huycke M.
    Arch Intern Med; 1989 Aug 01; 149(8):1873-5. PubMed ID: 2504123
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-level gentamicin-resistant enterococci: in vitro activity of double and triple combinations of antimicrobial drugs.
    Ferrara A, Dos Santos C, Cimbro M.
    Chemotherapy; 1996 Aug 01; 42(1):37-46. PubMed ID: 8751265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.